chart sample
TRANSCRIPT
© Synovate 2010 1
Opinion of overall appearance of the tea
Opinion of overall color of the tea
Opinion of clarity of the tea
Q21a. Which of these phrases best describes your opinion of the overall appearance of the drink made of the green tea we sent you to try?Q22. And which of these phrases best describes your opinion of the overall color of the drink?Q24a. Which of the following phrases best describes your opinion of the clarity of the green tea you just tried?A/B/C/D/E - Significantly higher than indicated group with 95% (upper case) and 90% (lower case) confidence level.
25%26%
24%
24%26%
24%
19%
25%21%
22%
29%
28%27%
38%
34%34%
38%
27%
23%
25%
22%
27%
37%
33%
33%
33%
35%
31%35%
32%
Excellent Very good
60%55%55%62%59%
T2B
BC
Appearance related measures – Unbranded
60%55%55%62%53%
60%55%55%62%55%
Lipton (N=219) [A] Bigelow (N=219) [B] Stash (N=219) [C] Salada (N=219) [D] Green (N=236) [E]
Comment
b
e
© Synovate 2010 2Draft Report
Overall Flavor
Too Strong Too WeakJust Right
Egg Flavor
10%10%
7%
6%6%
4%
8%8%
5%
82%76%
75%
81%84%
83%
70%78%
70%
8%14%
18%
12%11%
13%
22%15%
25%
6%
5%
3%
9%7%
5%7%
8%9%
83%78%
87%75%
75%64%
80%
78%
74%
17%
14%
23%
13%10%
8%18%
17%27%
Lemon Flavor
Too Strong Too WeakJust Right
Too Strong Too WeakJust Right
_____________Q18. What is your opinion of the strength of overall flavor of the mayonnaise? Q22. How would you the rate the strength of the egg flavor in the mayonnaise? Q23. How would you rate the strength of lemon flavor in the mayonnaise? A/B/C/D/E/F - Significantly higher than indicated group with 95% (upper case) and 90% (lower case) confidence level.
d
d
aD
BC
A
A
c
C
c
c
B
b
B
AE
e
e
aE
n Hellmann's (A) (n=159) Best Foods (B) (n=102) n Kraft (C) (n=160)n Safeway (D) (n=154) Kroger (E) (n=155) Wal-Mart (F) (n=155)
Just Right: Strength of Flavor Characteristics
Hellmann's has an advantage over Best Foods and Kraft for strength of egg flavor.Best Foods is considered too weak in lemon flavor and lags Hellmann's and Kroger on optimal ratings.
© Synovate 2010 3
Report writer text Finding B (Arial, 28pt)
Q2a.Q2b.
Types Purchased Past 3 Months
5
1
2
5
4
5
5
9
6
17
18
17
3
13
23
23
25
28
31
33
34
37
38
43
44
54
4
3
Donuts
Cereal Bars
Snack Cakes
Cupcakes
Muffins
Snack Bars
Cakes (Full Size)
Brownies
Pastries/Specialty
Danish
Snack Pies
Pies (Full Size)
Some other type
None of the above
%West
(n=285)Midwest/Southeast
(n=321)Northeast
(n=307) % %
3
1
4
3
3
1
13
5
5
25
20
16
2
10
19
22
22
27
30
23
44
36
30
53
51
55
2
1
3
2
5
3
5
2
17
6
3
13
22
15
1
10
18
21
24
30
28
18
48
30
32
43
48
50
1
3
Purchase Most Often Purchase P3M
© Synovate 2010 4
Report writer text Finding C (Arial, 28pt)
**Very Small Base*Small BaseQ3.
Primary Eater
44%
50%
52%
62%
60%
63%
50%
50%
56%
45%
45%
61%
44%
46%
43%
31%
35%
34%
31%
24%
27%
29%
31%
34%
26%
40%
10%
7%
18%
3%
6%
7%
26%
24%
15%
24%
21%
13%
17%Donuts (n=167,175,143)
Cereal Bars (n=135,163,137)
Snack Cakes (n=132,170,122)
Snack Bars (n=105,140,136)
Muffins (n=112,116,85)
Cupcakes (n=116,96,92)
Brownies (n=97,96,80)
Pastries/Specialty (n=87,85,85)
Cakes (Full Size) (n=102,74,52)
Danish (n=77,71,67)
Snack Pies (n=70,70,59)
Pies (Full Size) (n=69,61,51)
Some other type (n=39*,33*,29**)
Northeast
45%
58%
52%
64%
49%
65%
46%
35%
55%
44%
45%
63%
49%
26%
38%
31%
27%
34%
27%
29%
31%
24%
33%
29%
21%
26%
29%
4%
17%
9%
17%
8%
25%
34%
21%
23%
27%
16%
25%
46%
56%
40%
67%
44%
67%
46%
47%
57%
46%
41%
57%
44%
39%
31%
37%
25%
36%
26%
20%
14%
26%
29%
24%
28%
24%
15%
13%
23%
9%
20%
7%
34%
39%
17%
25%
35%
15%
32%
Midwest/Southeast West
Myself Other Adult Child
© Synovate 2010 5
Report writer text Finding C (Arial, 28pt)
**Very Small Base*Small BaseQ3.
Primary Eater
44%
50%
52%
62%
60%
63%
50%
50%
56%
45%
45%
61%
44%
46%
43%
31%
35%
34%
31%
24%
27%
29%
31%
34%
26%
40%
10%
7%
18%
3%
6%
7%
26%
24%
15%
24%
21%
13%
17%Donuts (n=167,175,143)
Cereal Bars (n=135,163,137)
Snack Cakes (n=132,170,122)
Snack Bars (n=105,140,136)
Muffins (n=112,116,85)
Cupcakes (n=116,96,92)
Brownies (n=97,96,80)
Pastries/Specialty (n=87,85,85)
Cakes (Full Size) (n=102,74,52)
Danish (n=77,71,67)
Snack Pies (n=70,70,59)
Pies (Full Size) (n=69,61,51)
Some other type (n=39*,33*,29**)
Northeast
45%
58%
52%
64%
49%
65%
46%
35%
55%
44%
45%
63%
49%
26%
38%
31%
27%
34%
27%
29%
31%
24%
33%
29%
21%
26%
29%
4%
17%
9%
17%
8%
25%
34%
21%
23%
27%
16%
25%
46%
56%
40%
67%
44%
67%
46%
47%
57%
46%
41%
57%
44%
39%
31%
37%
25%
36%
26%
20%
14%
26%
29%
24%
28%
24%
15%
13%
23%
9%
20%
7%
34%
39%
17%
25%
35%
15%
32%
Midwest/Southeast West
Myself Other Adult Child
© Synovate 2010 6
Report writer text Finding C (Arial, 28pt)
**Very Small Base*Small BaseQ3.
Primary Eater
44%
50%
52%
62%
60%
63%
50%
50%
56%
45%
45%
61%
44%
46%
43%
31%
35%
34%
31%
24%
27%
29%
31%
34%
26%
40%
10%
7%
18%
3%
6%
7%
26%
24%
15%
24%
21%
13%
17%Donuts (n=167,175,143)
Cereal Bars (n=135,163,137)
Snack Cakes (n=132,170,122)
Snack Bars (n=105,140,136)
Muffins (n=112,116,85)
Cupcakes (n=116,96,92)
Brownies (n=97,96,80)
Pastries/Specialty (n=87,85,85)
Cakes (Full Size) (n=102,74,52)
Danish (n=77,71,67)
Snack Pies (n=70,70,59)
Pies (Full Size) (n=69,61,51)
Some other type (n=39*,33*,29**)
Northeast
45%
58%
52%
64%
49%
65%
46%
35%
55%
44%
45%
63%
49%
26%
38%
31%
27%
34%
27%
29%
31%
24%
33%
29%
21%
26%
29%
4%
17%
9%
17%
8%
25%
34%
21%
23%
27%
16%
25%
46%
56%
40%
67%
44%
67%
46%
47%
57%
46%
41%
57%
44%
39%
31%
37%
25%
36%
26%
20%
14%
26%
29%
24%
28%
24%
15%
13%
23%
9%
20%
7%
34%
39%
17%
25%
35%
15%
32%
Midwest/Southeast West
Myself Other Adult Child
© Synovate 2010 7
54%
1% 4%10%
7%
1%22%
* Small BaseQ.7: How often do you experience the following?
Frequency Experience Condition – Among Total Users
Total Poison Ivy Users
(135)
Mean: 3.0
Once a week or more often
Every 2-3 weeks
Once a month
Every 2-3 months
Every 4-6 months
Once or twice a year
Less than once a year
50%
3% 6%8%
11%
22%
Total Poison Oak Users
(36)*
3.7
25%
9%
12%
22%
11%
16%
4%
Total Temporary RashOr Itch Caused By Insect Bites,
Allergic Reaction, Etc. Users(358)
11.6
8%
47%
9%
16%
8%
10%
3%
Total Eczema Users(79)
Mean: 28.7
5%
57%9%
10%
4%
12%
4%
Total Psoriasis Or SomeOther Chronic Condition Users
(105)
34.0
© Synovate 2010 8
54%
1% 4%10%
7%
1%22%
* Small BaseQ.7: How often do you experience the following?
Frequency Experience Condition – Among Total Users
Total Poison Ivy Users
(135)
Mean: 3.0
Once a week or more often
Every 2-3 weeks
Once a month
Every 2-3 months
Every 4-6 months
Once or twice a year
Less than once a year
50%
3% 6%8%
11%
22%
Total Poison Oak Users
(36)*
3.7
25%
9%
12%
22%
11%
16%
4%
Total Temporary RashOr Itch Caused By Insect Bites,
Allergic Reaction, Etc. Users(358)
11.6
8%
47%
9%
16%
8%
10%
3%
Total Eczema Users(79)
Mean: 28.7
5%
57%9%
10%
4%
12%
4%
Total Psoriasis Or SomeOther Chronic Condition Users
(105)
34.0
22
26
29
36
1
5
10
11
54
56
43
46
22
13
18
7
17
19
18
20
2
3
4
3
44
54
52
55
37
24
26
22
21
29
19
15
3
4
4
42
36
45
53
34
30
32
32
11
10
10
15
1
1
44
56
55
56
44
35
34
29
21
24
23
27
4
5
2
3
32
47
52
47
43
24
23
23
13
13
13
10
4
3
5
1
43
67
60
69
40
17
23
20
Perception of HPV Vaccination (1/2)
Connection creates value 9
Q23: With regards to the vaccine against Human Papillomavirus/cervical cancer, to what extent would you say that you agree with each of the following statements ?
Totally disagree Disagree somewhatAgree somewhat Totally agree
Spain YMNorway YM(623)
Denmark YM Portugal YM(76) (136)(109) (159)
YOUNG MEN
…is as important as
other recommended
vaccination
…is a vaccine I trust
…is supported by my doctor
…is a safe vaccine
TOTAL COUNTRIES
ST Agree
BASE : Aware of HPV vaccine /Cervical cancer vaccine
France YM(139)
81 %
78 %
78 %
77 %
76 %
70 %
61 %
53 %
83 %
84 %
83 %
89 %
75 %
71 %
75 %
70 %
88 %
91 %
89 %
85 %
76 %
68 %
78 %
85%
…is as important as other recommended vaccination
…is a vaccine I trust
…is supported by my doctor
…is a safe vaccine
…has demonstrated its efficacy
…is for girls only
…can also be administered to boys to prevent diseases in boys
1.0 2.0 3.0 4.0
Total countries NOR (GP) DEN (All) SP (Ped)POR (Ped) FRC
Perception of HPV Vaccination
Connection creates value 10
Q23: With regards to the vaccine against Human Papillomavirus/cervical cancer, to what extent would you say that you agree with each of the following statements ?
YOUNG MEN
BASE : Aware of HPV vaccine /Cervical cancer vaccine (623) (76) (109) (136) (159) (139)
After “burden” both Mothers and Young Men seem quite favorable towards HPV vaccination in boys/ym
Connection creates value 11
Reactions to HPV vaccination of BOYS
BASE : All
SpainNorway Denmark PortugalTOTAL COUNTRIES
151
50 3421 25 73
101
40 49 2 33 66 72
37 54
89% 84% 99% 91% 97%(86) (177)(135) (143)(743)
Mothers BOYS PC
Mothers BOYS CC
YOUNG MEN
122
51 34
(181) (176)(262) (141)(961)
31 26 71
82
41 49 2 35 64 71
41 51
90% 86 % 98 % 92 % 96 %
(152) (226)(120) (206)(910)
132 47 38152 51 32 191 51 29 10 54 36 5
250 42
83% 79% 90% 93% 85%
I am very unfavorable I am somewhat unfavorable I am somewhat favorable
In spite of the fact that the Young men seem to feel little affected personally, their attitude towards HPV vaccination in boys/ym is favorable
ST favorable
France
213 52 24
76 %
(202)
(201)
177 52 24
76 %
(200)
274 55 14
69%
2.2
3.6
2.5
3.7
3.9
4.2
3.8
4.9
2.0
3.5
2.2
3.9
3.7
4.0
3.6
5.8
2.3
4.0
2.3
3.6
3.9
4.5
4.1
4.7
69
67
67
53
49
42
40
23
64
73
73
56
64
48
38
26
Drivers for vaccination
Connection creates value 12
Q37a: What could be the reasons that you want your son to get vaccinated against the Human Papillomavirus ?
Q37b: Could you please rank the reasons you selected in order of their importance for you ?
Mothers BOYS PC
Drivers 1/2Spain Mothers Norway Mothers
(66) (153)Denmark Mothers
(131)Portugal Mothers
(142)TOTAL COUNTRIES
(652)
BASE Driver : Certainly or probably will get vaccinated or is already vaccinated BASE Rank : item quoted in Q37a
France Mothers(160)
I welcome any protection against cancers for my son
myself
Boys should have the same access to protection
as girls
I want to avoid any risk of the virus for my son
I want to avoid any risk of transmission of the virus
to future or current partners
I want to avoid genital warts for my son
Getting my son vaccinated will help to eradicate the
Human PapillomavirusI think that the vaccination
offers the best protection against Human Papillomavirus
I trust the previous success of girl’s vaccination
79
73
66
59
50
52
37
33
65
59
58
44
44
36
37
18
68
65
70
58
36
43
48
21
71
68
68
51
59
35
37
21
PC
PC
CC
RANK2.3
3.4
3.3
3.8
4.5
3.7
4.2
4.6
2.4
3.8
2.4
3.3
3.9
4.1
3.5
4.8
2.0
3.6
2.4
4.1
3.8
4.8
4.2
4.8
CC
CC
PC CC
In a typical month, how many new and restart prescriptions or orders do you write for each of the following agents?
140.0
140.0
140.0
140.0
140.0
Total(n=630)
Mean Among Total PhysiciansA/B/C indicates statistically significant difference @ 95% confidence level between countriesD/E indicates statistically significant difference @ 95% confidence level between specialties
US (A)
(n=321)France (B)
(n=155)Germany (C)
(n=154)PCP (D)
(n=280)Specialists (E)
(n=350)
Stub 1
Stub 1
Stub 1
Stub 1
Stub 1
QD
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
Top-2 Box Summary: Please use the following scale to indicate how much you agree or disagree with the following statements
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
Total(n=630)
% Among Total PhysiciansA/B/C indicates statistically significant difference @ 95% confidence level between countriesD/E indicates statistically significant difference @ 95% confidence level between specialties
US (A)
(n=321)France (B)
(n=155)Germany (C)
(n=154)PCP (D)
(n=280)Specialists (E)
(n=350)
Stub 1
Stub 1
Stub 1
Stub 1
Stub 1
Q5
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
Somewhat AgreeAgree Completely
Thinking about the next 100 patients you will see for each of the patient types listed below, how will you treat and/or
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
5% RRR (A)
(n=630)
Stub 1
Stub 1
Stub 1
Stub 1
Stub 1
Q6-6b
12% RRR (B)
(n=630)20% RRR (C)
(n=630)30% RRR (D)
(n=630)
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
0.9% Bleeding0.3% Bleeding
Mean % Among Physicians AskedLetter indicates statistically significant difference @ 95% confidence level between sub groups
Segment segments segz size pie
Segment15%
Segment25%
Segment25%
Segment33%
Segment2%
Breakdown of subgroup By Segment (n=366)
1. Size of Segment
Segment26%
Segment39%
Segment21%
Segment12%
Segment2%
Breakdown of subgroup By Segment (n=182)
Provides effective asthma control
Is associated with enhanced compliance
Effective forallergic rhinitis
Exhibits anti-inflammatory properties Prevents lung
remodeling
Reduces reliance on PRN short-acting beta-
agonists
Provides nocturnal control of asthma
Effect is evident on the 1st day of treatment
Provides real world effectiveness
Works in a high percentage of asthma
patients Is appropriate switch therapy for patients uncontrolled on an
inhaled corticosteroid
Has a favorable side effect profile
Is easy to use
Is effective for asthma patients with allergic
triggers Has a convenientdosing regimen
Is cost effective forthe patient
Has favorable managed care status
Is effective in blocking leukotrienes
Is not associated with systemic side effects
Prevents disease progression
Is an appropriate first-line monotherapy
maintenance medication for asthma
Derived vs. Stated Importance Map:
Sta
ted
Impo
rtanc
eLo
wH
igh
Derived Importance HighLow
Key DriversCost of Entry
Underlying DriversLeastInfluential
% Among Total Physicians - Adult Market N=284/288Importance: % of Physicians Who Find Attribute Most Influential When Prescribing for Asthma (Bradley-Terry Paired Comparison Analysis)Imagery: % of Physicians Selecting Brand as Most Strongly Associated with Statement (Maximum Benefit Differentiation) Letters denote statistically significant differences at the 95% confidence level between brands.Number denote statistically significant differences at the 95% confidence level between waves
Provides Effective Asthma Control
Importance Singulair® [A] Advair [B]
89%
80%
79%
76%
71%
70%
69%
82%
74%
75%
56%
74%
62%
55%
Alvesco [D]
Works In A High Percentage Of Asthma
Patients
Provides Real World Effectiveness
ExhibitsAnti-inflammatory
Properties
Reduces Reliance On PRN Short-acting
Beta-agonists
Is Appropriate Switch Therapy For Patients
Uncontrolled On An Inhaled Corticosteroid
Is Not Associated With Systemic Side Effects
8%
8%
16%
15%
8%
23%
86%
4%
6%
19%
8%
6%
25%
79%
90%
87%
81%
51%
88%
68%
5%
91%
87%
78%
56%
90%
70%
5%
1%
2%
2%
5%
1%
7%
3%
2%
2%
1%
10%
1%
5%
5%
Flovent [C]
1%
4%
2%
29%
3%
2%
7%
3%
5%
3%
26%
3%
1%
12%
CD ACD
D ACD AD
CD ACD
CD ACD
CD ACD C
BCD D
ACD
Importance / Imagery Charts
Q3/4
7/0512/05
ACD
D ACD8
CD ACD
ACD 8AD 8
D ACD
CD ACD C
BCD 8BD
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Has a favorable side effect profile Prevents lung remodeling Is an appropriate first-linemonotherapy maintenance
medication for asthma
Exhibits anti-inflammatoryproperties
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
Importance Singulair Advair Flovent Alvesco Upper parity Lower Parity
Competitive Performance Diagnostic Charts
Extremely Important
Extremely Unimportant
83%
Competitor Advantage
Parity Zone
Singulair® Advantage
Singulair® Best Brand %
Q3,4
Among Total Adult (PCP/Allr/PUD)Physicians.
12/057% 20% 8%
Competitive Performance Diagnostic Charts
4% 6% 5% 6% 6% 9%
Q5, 6
Among Total PED (GP/FPs/Allr/PED)Physicians.
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Provideseffective asthma
control
Preventsdisease
progression
Exhibits anti-inflammatory
properties
Reducesreliance on PRN
short-actingbeta-agonists
Prevents lungremodeling
Providesnocturnalcontrol ofasthma
Is anappropriate first-
linemonotherapymaintenance
medication forasthma
Indicated forpatients asyoung as 12months old
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
Importance Singulair Advair Flovent Alvesco Pulmicort Respules Upper parity Lower Parity
Extremely Important
Extremely Unimportant
Competitor Advantage
Parity Zone
Singulair® Advantage
Singulair® Best Brand % 28% 48%
12/05
PwC
Heat map (Q3 FY11)
21September 2011
Scoring methodThe chart above identifies systemic and isolated strengths and weaknesses in the survey results. The survey items used a five-point scale (Strongly Disagree, Disagree, Neutral, and Agree, and Strongly Agree). The last two response options are combined to form one "Agree Score" which is the one reported in the tables and charts. The higher the reported number, the more favorable the result. Unfavorable results are color-coded:
22
48
42
34d
88d
47
83D
73
34
2
1
4
19
4
1
1d
9
1
1
FY’10 (B)
FY’11 (C)
Martini & Rossi Asti (M&R) and Korbel are still the category leaders in Brand awareness, but M&R has lost awareness vs. two years ago. Korbel has also declined in brand awareness over the past 2 years but not significantly. This more gradual decline may be tied to Korbel’s large ad spend.
Brand Awareness Profiles
Q.1U/2U When you think of champagne or sparkling wine, what one brand first comes to mind? What other brands come to mind next? Q.1A You may have mentioned some of these already, but please use the list below to indicate which of these brands of champagne or sparkling wine you are aware of.
#Less than 0.5%NOTE: Competitive brands ranked on Est. Price Point
FY’09 (A)
Add chart to far right for FY12. Data should stay in same order as stubs shown on slide on Left. Reduce chart widths as
needed.Data file: 104712compaa01 (hold off on Martini Net for now)
Unaided First Brand Mentions: Table 1-B6Total Unaided Brand Mentions: Table 2-B6
Total Brand Awareness: Table 5-B6
Please update base sizes for FY12
44
53B
27
82
15AB
19AB
45
74
69
32
2
2
2
23
1
4
1
1
6
1a
FY’12 (D)
Martini/Martini & Rossi Asti
Ballatore
Yellow Tail Sparkling Wine
Freixenet
Korbel
Piper Sonoma
Mumm Napa
Chandon (Domaine Chandon)
Moet & Chandon White Star/Brut
Moet & Chandon Nectar
Veuve Clicquot Yellow Label
53d
48
38D
83
42
85D
70
36
3
2
4
17
2
1
1
1
1
5
48
49b
35d
86
22ABd
27ABd
43
80
68
33
1
2
5d
19
6a
1
7
Base: P12M C/SW Drinkers FY’09(204); FY’10(262); FY11(203); FY12(201) Unaided 1st Brand Mentions Unaided Brand Mentions Total Brand Awareness
23
Saw/Heard/Read Advertising – Top 10 Sources ListConsumers recollection of where they saw M&R advertising is unchanged from the past two years.
Q.3A In which of these places have you seen, heard or read anything about champagne or sparkling wine recently? Among P12M C&SW Drinkers aware of Advertising
In A Store/In-Store Display
Magazines
TV
In A Bar/Club/Lounge
In A Restaurant
Talking To Someone Else
RadioPosters, Billboards Or Other
Outdoor AdsDuty Free Shop
NewspapersThe Internet Or Email Or Text
MessageSome Other Place
60%
45%B
40%D
33%
27%
29%
13%
15%
15%
13%
13%
16%
60%
32%
33%
31%
25%
30%
17%
20%
15%
13%d
10%
11%
M/M&R FY09 (A)
M/M&R FY10 (B)
M/M&R FY11 (C)
M/M&R FY12 (D)
Base: Aware of Advertising for Brand (119) (126) (89) (90)
60%
40%
34%
34%
24%
22%
20%d
19%
15%
15%d
13%
12%
Add chart to far right for FY12. Data should stay in same order as stubs shown on slide on Left. Add base size for FY12.
Reduce chart widths as needed.Data file: 104712compaa01
Table 7-B6
66%
36%
26%
27%
26%
29%
11%
12%
17%
7%
14%
9%
24
Freixenet2009 2010 2011 2012
A B C D204 262 203 201
4 3 5 2
62 66 65 73
20 16 19 126 8 7 5
5 6 2 51 2 11 1
Chandon (Domaine Chandon)2009 2010 2011 2012
A B C D204 262 203 201
Korbel2009 2010 2011 2012
A B C DBase: Total 204 262 203 201
Martini/Martini & Rossi Asti2009 2010 2011 2012
A B C DBase: Total 204 262 203 201
7 3 3 6
5853 57 55
2327 22 25
9 8 10 63 6 6 61 2 11
0%
20%
40%
60%
80%
100%
6 6 8 58 13
19 23
37 3633 29
18 1413 14
22 23 18 243 4 4 24 5 5 2
Lover
Friend
Acquaintance
Familiar
Aware
Stranger
Rejecter
0%
20%
40%
60%
80%
100%
10 4 8 5
1712
14 18
3636 31 28
1918 16 22
1426 24 20
2 2 4 42 1 2 2Lover
Friend
Acquaintance
Familiar
Aware
Stranger
Rejecter
CommitmentM&R has declined in acquaintances adding to strangers over the past two years. At the same time Korbel has had a decline in Awares with an increase in strangers.
#- Less than .5%Q.27 Consideration, Q.4, Consumption
Add Chart for FY12 to each section (to the right of FY2012).
Data file: 104712compgmaa012009 – Table: 1-B309
2010 – Table: 1-B30122011 – Table: 1-B30152012 – Table: 1-B3018
25
55%
48%
50%
58%
42%
52%
46%
40%
34%
30%
30%
38%
28%
M&R Brand ImageryOver the course of the last two years, M&R has made significant headway on the majority of brand imagery attributes including affinity (brand for me), quality and value.
Base: Aware of Brand and Randomly Selected: FY 2009 (104), FY 2010 (118), FY 2011 (99), FY 2012 (93)Q.29 Using a scale from 5 to 1 where 5 means “Agree Completely” and 1 means “Disagree Completely”, please tell us how much you agree or disagree that each statement
describes the brands shown.
Martini/Martini & Rossi Asti FY09
(A)
Martini/Martini & Rossi Asti FY10
(B)
Is For Really Great Times With Friends
Is A Good Value For The Money
Is Good To Give As A Gift
Is Easy To Drink
Is Great For Home Entertaining
Not Only For Special Occasions
Is A Brand I'd Take To A Party
Smooth Tasting
Is A Brand For MeAn Informal Brand Of Champagne/Sparkling
WineHas A Sweeter Taste Than Other Brands
Is A High Quality Brand
Is For Fun Loving People
Is A Brand That Impresses Others
Truly Different From Other Brands
Shows Your Sense Of Style
Captures The Joy Of Living
Is Getting More Popular
Is For People Who Are Knowledgeable About Sparkling Wine And Champagne
Is An Imported Italian Brand
Top 2 Box (Agree Completely/Somewhat) Martini/Martini & Rossi Asti FY11
(C)
64%
60%a
64%A
65%
58%A
55%
59%AD
43%
51%A
44%A
34%
42%
42%A
68%AB
65%
65%A
63%a
62%AB
60%
60%AB
60%A
59%
58%d
55%Abd
54%A
51%AB
47%A
46%Ab
44%
41%AB
40%AB
39%a
37%AB
Add chart to far right for FY12. Add base size for FY12. Reduce chart widths as
needed. Order statements by M&RFY11 – use same statement order throughout rest
of imagery slides.Data file: 104712compaa01
Table: 213-B6
Martini/Martini & Rossi Asti FY12
(D)
67%AB
66%
66%A
69%A
72%AB
66%
69%AB
65%A
65%a
45%
42%
62%Ab
53%AB
56%Ab
49%AB
48%
48%AB
48%AB
39%
34%AB
26
= Rating is significantly higher than Martini & Rossi Asti
= Rating is significantly lower than Martini & Rossi Asti
M&R Brand Imagery
Note: Ballatore & Mumm Napa were not asked at Imagery/PersonalityQ.29 Using a scale from 5 to 1 where 5 means “Agree Completely” and 1 means “Disagree Completely”, please tell us how
much you agree or disagree that each statement describes the brands shown.
M&R is perceived to have a sweeter taste than other brands and is among the highest rated on quality and a brand that impresses others.
Top 2 Box (Agree Completely/Somewhat) Martini/ Martini & Rossi Asti
Yellow Tail Sparkling
Wine Freixenet KorbelPiper
Sonoma
Chandon (Domaine Chandon)
Moet & Chandon
White Star/Brut
Moet & Chandon
NectarVeuve Clicquot
Yellow Label$14.99 $8.99 $11.99 $13.99 $14.99 $19.99 $34.99 $44.99 $44.99
Base: Aware of Brand And Randomly Selected 93 58 41 92 18 53 76 73 33Is For Really Great Times With Friends 67c 66c 49 68C 50 62 66c 70C 70cIs A Good Value For The Money 66fGH 67fGH 54 70cFGH 50 49 50 45 55Is Good To Give As A Gift 66 67 66 65 67 70 79aD 79AD 82aDIs Easy To Drink 69 64 61 72 56 64 64 66 79ceIs Great For Home Entertaining 72C 72c 54 72C 61 66 71c 70c 82CfNot Only For Special Occasions 66e 66 56 61 44 55 57 58 58Is A Brand I'd Take To A Party 69E 64e 56 67E 39 58 75CEf 68E 82bCdEFSmooth Tasting 65f 59 56 66F 56 49 63 68F 79BCeFgIs A Brand For Me 65Cf 53 41 61C 61 49 64Cf 63C 73bCF
An Informal Brand Of Champagne/Sparkling Wine 45 72ACDEFGHI 39 48gh 44 38 34 34 33
Has A Sweeter Taste Than Other Brands 42 45 29 34 33 30 43 44 39Is A High Quality Brand 62Bd 36 59B 49 44 57B 76ABcDEF 82ABCDEF 85ABCDEFIs For Fun Loving People 53c 71ACdEFg 37 58C 39 49 57C 59C 64CeIs A Brand That Impresses Others 56BF 34 46 45 56 38 71ABCDF 77ABCDeF 67BcDFTruly Different From Other Brands 49cd 36 34 37 50 47 54BCD 55BCD 55bcdShows Your Sense Of Style 48 38 51 51 56 45 66ABdF 66ABdF 55Captures The Joy Of Living 48 50 39 47 39 49 57c 56c 45Is Getting More Popular 48 62aCDF 37 46 44 38 61CdF 51 58cfIs For People Who Are Knowledgeable About Sparkling Wine And Champagne 39 36 37 32 44 51D 66ABCDf 59ABCD 67ABCD
Is An Imported Italian Brand 34BD 17 29 16 28 25 25 26 27
Replace with FY12 data only. Order statements same as previous slide. The Pert Group will add
the significance arrows later.Data file: 104712compaa01
Table: 20-B1018